135 related articles for article (PubMed ID: 37184881)
1. LENS: Landscape of Effective Neoantigens Software.
Vensko SP; Olsen K; Bortone D; Smith CC; Chai S; Beckabir W; Fini M; Jadi O; Rubinsteyn A; Vincent BG
Bioinformatics; 2023 May; 39(6):. PubMed ID: 37184881
[TBL] [Abstract][Full Text] [Related]
2. ScanNeo2: a comprehensive workflow for neoantigen detection and immunogenicity prediction from diverse genomic and transcriptomic alterations.
Schäfer RA; Guo Q; Yang R
Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37882750
[TBL] [Abstract][Full Text] [Related]
3. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
[TBL] [Abstract][Full Text] [Related]
4. CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens.
Bais P; Namburi S; Gatti DM; Zhang X; Chuang JH
Bioinformatics; 2017 Oct; 33(19):3110-3112. PubMed ID: 28605406
[TBL] [Abstract][Full Text] [Related]
5. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
[TBL] [Abstract][Full Text] [Related]
6. TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes.
Zhang G; Chitkushev L; Olsen LR; Keskin DB; Brusic V
BMC Bioinformatics; 2021 Apr; 22(Suppl 8):40. PubMed ID: 33849445
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
8. ProTECT-Prediction of T-Cell Epitopes for Cancer Therapy.
Rao AA; Madejska AA; Pfeil J; Paten B; Salama SR; Haussler D
Front Immunol; 2020; 11():483296. PubMed ID: 33244314
[TBL] [Abstract][Full Text] [Related]
9. INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery.
Zhang J; Mardis ER; Maher CA
Bioinformatics; 2017 Feb; 33(4):555-557. PubMed ID: 27797777
[TBL] [Abstract][Full Text] [Related]
10. NeoFuse: predicting fusion neoantigens from RNA sequencing data.
Fotakis G; Rieder D; Haider M; Trajanoski Z; Finotello F
Bioinformatics; 2020 Apr; 36(7):2260-2261. PubMed ID: 31755900
[TBL] [Abstract][Full Text] [Related]
11. FusionNeoAntigen: a resource of fusion gene-specific neoantigens.
Kumar H; Luo R; Wen J; Yang C; Zhou X; Kim P
Nucleic Acids Res; 2024 Jan; 52(D1):D1276-D1288. PubMed ID: 37870454
[TBL] [Abstract][Full Text] [Related]
12. HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design.
Hu W; He M; Li L
PLoS One; 2020; 15(2):e0229327. PubMed ID: 32106223
[TBL] [Abstract][Full Text] [Related]
13. Sources of Cancer Neoantigens beyond Single-Nucleotide Variants.
Capietto AH; Hoshyar R; Delamarre L
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077528
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens.
Khodadoust MS; Olsson N; Wagar LE; Haabeth OA; Chen B; Swaminathan K; Rawson K; Liu CL; Steiner D; Lund P; Rao S; Zhang L; Marceau C; Stehr H; Newman AM; Czerwinski DK; Carlton VE; Moorhead M; Faham M; Kohrt HE; Carette J; Green MR; Davis MM; Levy R; Elias JE; Alizadeh AA
Nature; 2017 Mar; 543(7647):723-727. PubMed ID: 28329770
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the immunological effects of 5-azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.
Frøsig TM
Dan Med J; 2015 Aug; 62(8):B5144. PubMed ID: 26239596
[TBL] [Abstract][Full Text] [Related]
16. nextNEOpi: a comprehensive pipeline for computational neoantigen prediction.
Rieder D; Fotakis G; Ausserhofer M; René G; Paster W; Trajanoski Z; Finotello F
Bioinformatics; 2022 Jan; 38(4):1131-1132. PubMed ID: 34788790
[TBL] [Abstract][Full Text] [Related]
17. Population-level distribution and putative immunogenicity of cancer neoepitopes.
Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations.
Hansen UK; Ramskov S; Bjerregaard AM; Borch A; Andersen R; Draghi A; Donia M; Bentzen AK; Marquard AM; Szallasi Z; Eklund AC; Svane IM; Hadrup SR
Front Immunol; 2020; 11():373. PubMed ID: 32226429
[TBL] [Abstract][Full Text] [Related]
19. Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines.
Sinnathamby G; Lauer P; Zerfass J; Hanson B; Karabudak A; Krakover J; Secord AA; Clay TM; Morse MA; Dubensky TW; Brockstedt DG; Philip R; Giedlin M
J Immunother; 2009 Oct; 32(8):856-69. PubMed ID: 19752748
[TBL] [Abstract][Full Text] [Related]
20. Assessment of cancer and virus antigens for cross-reactivity in human tissues.
Jaravine V; Raffegerst S; Schendel DJ; Frishman D
Bioinformatics; 2017 Jan; 33(1):104-111. PubMed ID: 27614350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
